(EMAILWIRE.COM, April 09, 2019 ) The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing..

Glucose monitoring tests are expected to account for the largest share during the forecast period

Based on product, the OTC Test market is segmented into glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and fecal occult tests. Glucose monitoring tests dominated the OTC Test market in 2018. Market growth can largely be attributed to the growing global prevalence of diabetes, ongoing technological advancements in blood glucose self-monitoring devices, and growing patient awareness about the benefits of these tests.

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78819178

Lateral flow assays segment is projected to witness the highest growth in the OTC test market during the forecast period.

On the basis of technology, the OTC Test market is segmented into lateral flow assays, immunoassays, and dipsticks. The lateral flow assays segment is expected to witness high growth in the coming years. The growth of this segment can be attributed to the increasing focus of manufacturers on the development of innovative LFA-based OTC devices for the confirmation of pregnancy (using hCG levels) and ovulation, screening for infectious diseases, and testing for drugs of abuse.

North America is expected to account for the largest market share during the forecast period.

Based on region, the OTC Test market is broadly divided into North America, Europe, the Asia Pacific, and the RoW. In 2018, North America accounted for the largest share of the OTC Test market. The large share of this region can be attributed to the growing prevalence of lifestyle diseases, an increasing number of product approvals, and rising government initiatives in this region.

The prominent players in the global OTC Test market are OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=78819178

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com